LGND - Multiplikator Forward P/S Ligand Pharmaceuticals

Logo korporat perusahaan ligand.com (LGND)

The expected P/S ratio reflects the valuation dynamics of Ligand Pharmaceuticals (LGND), with the latest value recorded as 5.20. A stable liquidity surplus driven by royalties minimizes capital expenditures. High return on assets is supported by a diversified patent portfolio. Meanwhile, Ligand Pharmaceuticals relies on outsourcing production and trials, concentrating its resources exclusively on the discovery of promising molecules.

ligand.com - Prakiraan rega marang pendapatan LGND (periode 04.07.2022 - 16.11.2026)

Ligand Pharmaceuticals - rincian analitis lan metrik utama (LGND)

- rega pasar lan target rega analis:
Pambiji fundamental perusahaan:Ligand Pharma (LGND)
Produk asli Ligand Corp

Market expectations for the P/S ratio of Ligand Pharmaceuticals (LGND) reflect a high valuation of its resilience due to a royalty model that eliminates direct commercialization costs. The current value of 5.20 measures the ratio of market capitalization to projected revenue, allowing investors to determine whether the asset is overbought or searching for a price floor within the cyclical range of fundamental value through Ligand Pharmaceuticals (LGND) P/S expectations.

Pesaing wigati

Multiplikator Forward P/S HLN (Haleon PLC)|Multiplikator Forward P/S Kenvue Corp KVUE|Verona Pharma PLC - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep jyongbio.com|Amneal Pharmaceuticals Inc (AMRX) - Rasio rega marang prakiraan pendapatan|Perrigo Company PLC - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan alvotech.com|Multiplikator Forward P/S Liquidia Technologies|Rasio rega marang prakiraan pendapatan Galapagos Genomics (GLPG)|ANIP: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S MNKD (MannKind Corp)|Rasio kapitalisasi marang dodolan sing dikarepake Amphastar (AMPH)|PCRX: Multiplikator forward rega marang pendapatan|SPRY - Multiplikator Forward P/S|Theravance Biopharma, Inc. (TBPH) - Rasio rega marang prakiraan pendapatan|AQST (Aquestive Therapeutics) - Rasio rega marang prakiraan pendapatan|SCPH (scpharmaceuticals.com) - Multiplikator Forward P/S|TECX: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Tonix Pharmaceuticals Inc. (TNXP)|SXTC (SXT Pharmaceuticals) - Rega forward marang dodolan|Multiplikator Forward P/S EPRX (Eupraxia Pharmaceuticals)|Rega forward marang dodolan BHST|Invizyne Technologies - Multiplikator Forward P/S|oramed.com (ORMP) - Multiplikator forward rega marang pendapatan|ENTX (enterabio.com) - Multiplikator forward rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan HYFT|ABVC (ABVC BioPharma, Inc) - Multiplikator Forward P/S|Multiplikator Forward P/S cumberlandpharma.com|Rasio rega marang prakiraan pendapatan Quantum BioPharma (QNTM)|FibroGen (FGEN) - Prakiraan rega marang pendapatan|Multiplikator Forward P/S TELO (telomirpharma.com)|RANI - Multiplikator forward rega marang pendapatan|SNYR - Rasio rega marang prakiraan pendapatan|rallybio.com - Rasio rega marang pendapatan sing dikarepake|LEXX: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Pulmatrix Inc|PTHL (Pheton Holdings) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Aptorum Group Limited APM|Rasio rega marang prakiraan pendapatan Lyra Therapeutics (LYRA)|Multiplikator forward rega marang pendapatan Impact BioMedical Inc IBO|Rasio rega marang prakiraan pendapatan tnfpharma.com TNFA|Rega forward marang dodolan YCBD|PainReform Ltd - Multiplikator Forward P/S|Altamira Therapeutics Ltd (CYTO) - Multiplikator forward rega marang pendapatan|lipella.com (LIPO) - Rasio rega marang prakiraan pendapatan|OptiNose (OPTN) - Multiplikator Forward P/S|PIRS (Pieris Pharmaceuticals Inc) - Multiplikator Forward P/S|PROC: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Petros Pharmaceuticals, Inc. (PTPI)|Multiplikator Forward P/S Qilian International Corp (QLI)|ACELYRIN, Inc. - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S tffpharma.com TFFP